Li, Zhenwei
Gu, Shenjia
Li, Jiajun
Zhang, Guomin
Wu, Zheng
Lin, Hongbo
Chen, Kan
Xu, Zhexin
Fu, Chuanxi https://orcid.org/0000-0003-3458-8386
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA (14302)
Article History
Received: 3 December 2025
Accepted: 20 January 2026
First Online: 4 February 2026
Declarations
:
: The authors, including Zhenwei Li, Shenjia Gu, Jiajun Li, Guomin Zhang, Zheng Wu, Hongbo Lin, Kan Chen, Zhexin Xu and Chuanxi Fu, declare that they have no conflicts of interest.
: The study protocol was reviewed and approved by the Ethics Committee of Zhejiang Chinese Medical University (approval no. AF-20220921-1). This study utilised de-identified data from existing databases and was conducted in accordance with the principles of the Declaration of Helsinki and its subsequent amendments. As this was a database-based study, the requirement for patient consent was waived by the institutional review board.